The results we obtained showed that ZFR, ABCB10, and OSMR mutations were associated with higher KRAS expression levels, while MAP3K10, TRIM71, and G3BP1 mutations were associated with higher CD44 expression levels in CRC compared to the wild-type. This evidence concerns the gene CD44 and colorectal carcinoma.